Scott Reed is co-chair of Venable's IP Litigation – Life Sciences Group. Scott has served as lead trial counsel in complex patent litigations involving pharmaceuticals, biotechnology, chemicals, medical devices, and electronic and computer technologies, in bench and jury trials in federal and state court and in contested proceedings before the U.S. Patent and Trademark Office. Before joining Venable, Scott spent his entire career at Fitzpatrick, Cella, Harper & Scinto, where he chaired the Litigation Practice Group and served as a member of the Management Committee.
Scott is known as a “consummate trial lawyer who discerns how to persuade the judge and jurors” and who produces “consistently excellent results” (IAM Patent 1000, 2012). He is a “versatile operator with extensive first-chair experience” (IAM Patent 1000, 2013) and brings “a lot of sage advice and experience” (Legal 500, 2012) as well as “his enthusiasm to cases, leading a professional team” (Legal 500, 2008).